Mycoplasma genitalium and Other Reproductive Tract Infections in Pregnant Women, Papua New Guinea, 2015-2017

Emerg Infect Dis. 2021 Mar;27(3):894-904. doi: 10.3201/eid2703.201783.

Abstract

Much about the range of pathogens, frequency of coinfection, and clinical effects of reproductive tract infections (RTIs) among pregnant women remains unknown. We report on RTIs (Mycoplasma genitalium, Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Treponema pallidum subspecies pallidum, bacterial vaginosis, and vulvovaginal candidiasis) and other reproductive health indicators in 699 pregnant women in Papua New Guinea during 2015-2017. We found M. genitalium, an emerging pathogen in Papua New Guinea, in 12.5% of participants. These infections showed no evidence of macrolide resistance. In total, 74.1% of pregnant women had >1 RTI; most of these infections were treatable. We detected sexually transmitted infections (excluding syphilis) in 37.7% of women. Our findings showed that syndromic management of infections is greatly inadequate. In total, 98.4% of women had never used barrier contraception. These findings will inform efforts to improve reproductive healthcare in Papua New Guinea.

Keywords: Chlamydia trachomatis; Mycoplasma genitalium; Neisseria gonorrhoeae; Papua New Guinea; Treponema pallidum; Trichomonas vaginalis; bacteria; bacterial vaginosis; fungi; pregnancy; pregnant women; reproductive tract infections; sexually transmitted infections; vulvovaginal candidiasis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents
  • Chlamydia Infections*
  • Chlamydia trachomatis
  • Drug Resistance, Bacterial
  • Female
  • Gonorrhea*
  • Humans
  • Macrolides
  • Mycoplasma Infections*
  • Mycoplasma genitalium*
  • Neisseria gonorrhoeae
  • Papua New Guinea
  • Pregnancy
  • Pregnant Women
  • Reproductive Tract Infections*
  • Sexually Transmitted Diseases*

Substances

  • Anti-Bacterial Agents
  • Macrolides